000 01670 a2200445 4500
005 20250517171748.0
264 0 _c20180530
008 201805s 0 0 eng d
022 _a2171-8695
024 7 _a10.7399/fh.10805
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJuanbeltz Zurbano, Regina
245 0 0 _aComplementary medicine use in cancer patients receiving intravenous antineoplastic treatment.
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_cSep 2017
300 _a589-600 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aComplementary Therapies
650 0 4 _aCross-Sectional Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aSpain
650 0 4 _aSurveys and Questionnaires
650 0 4 _aYoung Adult
700 1 _aPérez-Fernández, Mª Dolores
700 1 _aTirapu Nicolás, Bianka
700 1 _aVera García, Ruth
700 1 _aDe la Cruz Sánchez, Susana
700 1 _aSarobe Carricas, María Teresa
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 41
_gno. 5
_gp. 589-600
856 4 0 _uhttps://doi.org/10.7399/fh.10805
_zAvailable from publisher's website
999 _c27503857
_d27503857